Replies to post #286862 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

You know, one little detail regarding the IMUC control arm that you used to represent the control arm in the DCVax trial... the control arm in the IMUC trial received autologous monocytes (basically unactivated dendritic cells) as their control-arm treatment.

What do you think was the placebo in the -L trial?

BTW, I do not think it matters but I did dig into this issue a bit. The use of autologous monocytes has been studied as a possible treatment. Though it showed some immuno activity, did not do anything clinically. So I would say the placebo in both trials is a good placebo.